Prepregnancy diabetes and risk of placental vascular disease

Diabetes Care

Volumn 30, Issue 10, 2007, Pages 2496-2498

  Becker, Taryn ^a,c   Vermeulen, Marian J ^a   Wyatt, Philip R ^b   Meier, Chris ^c   Ray, Joel G ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b York Central Hospital Richmond Hill   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; RISK FACTOR; VASCULAR DISEASE;

ADULT; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPERTENSION; PARITY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR DISEASES;

EID: 35148877209     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0364     Document Type: Article

References (17)

1. Khan KS, Daya S: Plasma glucose and preeclampsia. Int J Gynecol Obstet 53:111-116, 1996
2. Solomon CG, Graves SW, Greene MF, Seely EW: Gluocse intolerance as a predictor of hypertension in pregnancy. Hypertension 23:717-721, 1994
3. Innes KE, Wismatt JH, McDuffie R: Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol 97:905-910, 2001
4. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA: Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366:1797-1803, 2005
5. O'Brien TE, Ray JG, Chan WS: Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14:368-374, 2003
6. Roberts JM: Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16:5-15, 1998
7. Chambers JD, Fusi I, Malik IS, Haskard DO, De Swiet M, Kooner JS: Association of maternal endothelial dysfunction with preeclampsia. JAMA 285:1607-1612, 2001
8. Ray JG, Vermeulen MJ, Schull MJ, Mc-Donald S, Redelmeier DA: Metabolic syndrome and the risk of placental dysfunction. J Obstet Gynaecol Can 27:1095-1101, 2005
9. Ray JG, Vermeulen MJ, Meier C, Wyatt PR: Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes. QJM 97:651-653, 2004
10. Ray JG, Vermeulen MJ, Shapiro JL, Kenshole AB: Maternal and neonatal outcomes in the pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT Study. QJM 94:347-356, 2001
11. Ananth CV, Oyelese Y, Yeo L, Pradhan A, Vintzileos AM: Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. Am J Obstet Gynecol 192:191-198, 2005
12. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO: Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 28: 1599-1603, 2005
13. Oyelese Y, Ananth CV: Placental abruption. Obstet Gynecol 108:1005-1016, 2006
14. Yucesoy G, Ozkan S, Bodur H, Tan T, Calikan E, Vural B, Corakci A: Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet 273:43-49, 2005
15. Nachum Z, Ben-Shlomo I, Weiner E, Shalev E: Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomized controlled trial. BMJ 319:1223-1227, 1999
16. Cetin I, Foidart JM, Miozzo M, Raun T, Jansson T, Tsatsaris V, Reik W, Cross J, Hauguel-de-Mouzon S, Illsley N, Kingdom J, Huppertz B: Fetal growth restriction: a workshop report. Placenta 25:753-757, 2004
17. Temple RC, Aldridge A, Stanley K, Murphy HR: Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type 1 diabetes. BJOG 113:1329-1332, 2006